EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transmembrane Protein TMEM59L Modulates 5‐ FU Resistance via PTPRN ‐Mediated DNA Damage Repair in Colorectal Cancer

Wenzhi Jin iD, Qiang Ma, Zenghui Ma, Jianhua Hou, Fenming Wang, Huiqing Kang, Chen Wang, Xiaoliang Wang iD, Feng Liu

Cancer Reports · 2026

DOI: 10.1002/cnr2.70448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Wenzhi Jin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Pudong Hospital Affiliated to Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Fluorouracil, Colorectal Neoplasms, Drug Resistance, Neoplasm, Membrane Proteins. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inner Mongolia Science & Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy resistance in colorectal cancer (CRC) is often mediated by enhanced DNA damage repair (DDR). Transmembrane protein TMEM59L is implicated in cancer progression, but its role in CRC chemoresistance is unclear. We investigated whether TMEM59L regulates 5‐fluorouracil (5‐FU) sensitivity through PTPRN‐mediated DDR.

Aims

This study aimed to investigate the role of TMEM59L in regulating PTPRN‐mediated DNA damage repair and its impact on 5‐FU sensitivity in colorectal cancer, with the goal of identifying potential therapeutic targets to overcome chemoresistance. Methods and Results Bioinformatics analyses assessed TMEM59L/PTPRN expression and prognosis in CRC cohorts. Gain‐ and loss‐of‐function experiments were conducted in CRC cell lines (HCT116, SW480) and their 5‐FU‐resistant derivatives. Cell proliferation, migration, invasion, apoptosis, DNA damage, and reactive oxygen species (ROS) were measured. Protein interactions were examined by Western blot and immunofluorescence. A xenograft model in nude mice validated the TMEM59L/PTPRN axis on tumor growth, stemness, and EMT markers. TMEM59L expression was elevated in metastatic lesions and associated with poor CRC patient survival. Functionally, TMEM59L promoted malignant behaviors and epithelial–mesenchymal transition. It was upregulated in 5‐FU‐resistant cells and non‐responsive patients. TMEM59L knockdown sensitized cells to 5‐FU, increasing ROS, DNA damage, and apoptosis, while its overexpression induced resistance. Mechanistically, TMEM59L regulated 5‐FU‐induced DNA damage and ROS through PTPRN. PTPRN overexpression reversed the sensitization caused by TMEM59L silencing. In vivo, TMEM59L knockdown enhanced 5‐FU's antitumor effect, which was counteracted by PTPRN overexpression.

Conclusion

The TMEM59L/PTPRN axis is a key regulator of DDR and 5‐FU resistance in CRC. TMEM59L promotes chemoresistance via PTPRN by enhancing DNA repair and reducing ROS‐mediated apoptosis. Targeting this pathway may offer a novel strategy to overcome 5‐FU resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorouracilColorectal NeoplasmsDrug Resistance, NeoplasmMembrane ProteinsDNA RepairHumansAnimalsMiceDNA DamageXenograft Model Antitumor AssaysMice, NudeAntimetabolites, AntineoplasticMaleApoptosisFemaleCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticHCT116 Cells

Stichwörter der Autor:innen

DNA damage repairTMEM59Lcolorectal cancerdrug resistance mechanismstransmembrane protein

Substanzen

FluorouracilMembrane ProteinsAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Pudong Hospital Affiliated to Fudan University, Shanghai, China.
  • Department of General Surgery, The People's Hospital of Wuhai Inner Mongolia, Wuhai, Inner Mongolia, China.
  • Department of Pediatric Surgery, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

ORCID-Profile: Wenzhi Jin, Xiaoliang Wang

Förderung

  • Inner Mongolia Science & Technology Plan

Zitieren

APA

Jin, W., Ma, Q., Ma, Z., Hou, J., Wang, F., Kang, H., Wang, C., Wang, X., & Liu, F. (2026). Transmembrane Protein TMEM59L Modulates 5‐ FU Resistance via PTPRN ‐Mediated DNA Damage Repair in Colorectal Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70448

Vancouver

Jin W, Ma Q, Ma Z, Hou J, Wang F, Kang H, et al. Transmembrane Protein TMEM59L Modulates 5‐ FU Resistance via PTPRN ‐Mediated DNA Damage Repair in Colorectal Cancer. Cancer Reports. 2026. doi:10.1002/cnr2.70448

BibTeX
@article{Jin2026,
  author = {Jin, Wenzhi and Ma, Qiang and Ma, Zenghui and Hou, Jianhua and Wang, Fenming and Kang, Huiqing and Wang, Chen and Wang, Xiaoliang and Liu, Feng},
  title = {Transmembrane Protein TMEM59L Modulates 5‐ FU Resistance via PTPRN ‐Mediated DNA Damage Repair in Colorectal Cancer},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70448}
}
Kostenlos starten →